All4NutraNo products in the cart.
All4NutraStartseite » News » COVID-19 » Page 2
Ever since the development of the first vaccine, vaccination has had the great impact on global health, leading to the...
Neutralising monoclonal antibody (mAb) is an important weapon in our arsenal for combating respiratory viral infections. However, the effectiveness of...
Messenger RNA (mRNA) lipid nanoparticles (LNPs) have emerged at the forefront during the COVID-19 vaccination campaign. Despite their tremendous success,...
Coronavirus disease-19 (COVID-19) emerged in December 2019 and quickly spread, giving rise to a pandemic crisis. Therefore, it triggered tireless...
Lipid nanoparticles (LNPs) are the most clinically advanced delivery vehicles for RNA and have enabled the development of RNA-based drugs...
The development of vaccines against SARS-CoV2 brought about several challenges, including the management of hypersensitivity reactions to these formulations. The...
This work aimed to select tablet diluent of Boesenbergia rotunda (L.) Mansf. extract tablet. Three tablet diluents, including microcrystalline cellulose (MCC), spray-dried...
The low water solubility of baricitinib (BCT) limits the development of new formulations for the topical delivery of the drug....
COVID-19 is caused by the infection of the lungs by SARS-CoV-2. Monoclonal antibodies, such as sotrovimab, showed great efficiency in...
The present work was conducted with the aim to formulate and evaluate the immediate release of 1000 mg tablets containing...
Copyright: PharmaExcipients AG